Current Insights into the Pathogenesis of Graves' Ophthalmopathy.

  title={Current Insights into the Pathogenesis of Graves' Ophthalmopathy.},
  author={Rebecca S. Bahn},
  journal={Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme},
  volume={47 10},
Environmental, genetic, and immune factors are at play in the development of the variable clinical manifestations of Graves' ophthalmopathy (GO). Among the environmental contributions, smoking is the risk factor most consistently linked to the development or worsening of the disease. The close temporal relationship between the diagnoses of Graves' hyperthyroidism and GO have long suggested that these 2 autoimmune conditions may share pathophysiologic features. The finding that the thyrotropin… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS


Publications citing this paper.
Showing 1-10 of 24 extracted citations


Publications referenced by this paper.
Showing 1-10 of 62 references

Randomized controlled trial of rituximab in patients with Graves’ orbitopathy

  • MN Stan, JA Garrity, BG Carranza Leon, T Prabin, EA Bradley, RS. Bahn
  • J Clin Endocrinol Metab
  • 2015

Similar Papers

Loading similar papers…